Our goal was to delineate parameters involved in the detection of local recurrences of cancer after breast conservation therapy, and to further define standardized follow-up strategies for surveillance of the breast after irradiation. We retrospectively evaluated 152 patients treated with breast conservation therapy who had received a median of 86 months of consecutive clinical and radiographic follow-up a t the University of Texas M. D. Anderson Cancer Center from 1978 t o 1989. All mammograms were reevaluated by a single radiologist (B.S.) who had no knowledge of the physical or pathologic findings.Local recurrences were found in 13 patients (9%), with a mean time t o recurrence of 51 months (median time, 37 months). Age, tumor size, margin status, nuclear grade, estrogen receptor status, nodal status, and the presence of extranodal extension were similar in patients with or without local recurrence. The primary method of detection was physical examination in 10 of the 13 patients (77%); only 3 occult local recurrences were detected by mammography alone. The 13 patients with local recurrences underwent an average number of 14 physical examinations and 5 mammograms in the follow-up period prior t o the detection of local recurrence.Our data suggested that, in patients with early stage breast cancer, the incidence of local recurrence after breast conservation therapy is relatively low. Most local recurrences occurred 2 years after breast conservation therapy and were detected by physical examinations. Yearly diagnostic mammograms after breast conservation therapy are sufficient and may complement thorough physical examinations. A new baseline mammogram t o evaluate the treated breast at 6 months, after irradiation changes have stabilized, may be useful for future mammogram comparisons. w Key Words: breast conservation, local recurrence, mammography reast conservation therapy (BCT) is widely used to-B day to manage patients who have stage I or I1 breast cancer. The overall survival after BCT has been shown to be equivalent to a complete mastectomy (1-3), although the rate of locoregional failure following BCT ranges from 5% to 10% at 5 years and 10% to 15% at 10 years (4-6). Adequate follow-up of patients treated with BCT includes patient breast self-examinations, periodic examinations by a physician, and serial rnammograms, but the sequence and frequency of these assessments are often approached with anecdotal strategies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.